The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.

Hypoxia-inducible factor-1 (HIF) is regulated by oxygen-dependent prolyl hydroxylation. Of the three HIF prolyl hydroxylases (PHD1, 2 and 3) identified, PHD3 exhibits restricted substrate specificity in vitro and is induced in different cell types by diverse stimuli. PHD3 may therefore provide an in...

Bibliografske podrobnosti
Main Authors:	Masson, N, Appelhoff, R, Tuckerman, JR, Tian, Y, Demol, H, Puype, M, Vandekerckhove, J, Ratcliffe, P, Pugh, C
Format:	Journal article
Jezik:	English
Izdano:	2004

Podobne knjige/članki

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
od: McNeill, L, et al.
Izdano: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
od: Tuckerman, JR, et al.
Izdano: (2004)

Assembly and substrate recognition properties of human CCT subunits of the TRiC chaperonin
od: Sergeeva, Oksana A
Izdano: (2015)

Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
od: Appelhoff, R, et al.
Izdano: (2004)

Regulation of HIF: prolyl hydroxylases.
od: Stolze, I, et al.
Izdano: (2006)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
od: Tian, Y, et al.
Izdano: (2006)

The chaperonin TRiC forms an oligomeric complex in the malaria parasite cytosol
od: Spillman, Natalie J., et al.
Izdano: (2018)

Structural and functional characterisation of the group II chaperonin CCT/TRiC
od: Kelly, J
Izdano: (2020)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
od: Cockman, M, et al.
Izdano: (2019)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
od: Schlemminger, I, et al.
Izdano: (2003)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
od: Masson, N, et al.
Izdano: (2003)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
od: Mole, D, et al.
Izdano: (2003)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
od: Chowdhury, R, et al.
Izdano: (2016)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
od: Chan, M, et al.
Izdano: (2016)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
od: Astuti, D, et al.
Izdano: (2010)

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
od: Astuti, D, et al.
Izdano: (2011)

Substrate selectivity of prolyl hydroxylases
od: McDonough, M
Izdano: (2018)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
od: Hewitson, K, et al.
Izdano: (2007)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
od: Yeh, TL, et al.
Izdano: (2017)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
od: Chowdhury, R, et al.
Izdano: (2013)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
od: Willam, C, et al.
Izdano: (2006)

Synthesis And Characterization Of Potential Human Hypoxia Inducible Factor (Hif) Prolyl Hydroxylase Domain 2 (Phd-2) Inhibitors
od: Toh, Lee Roy
Izdano: (2021)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
od: Giatromanolaki, A, et al.
Izdano: (2008)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway
od: Giatromanolaki, A, et al.
Izdano: (2008)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
od: Holt-Martyn, JP, et al.
Izdano: (2019)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
od: Wijeyekoon, JB
Izdano: (2013)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
od: Richardson, NL, et al.
Izdano: (2021)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
od: Yeoh, K, et al.
Izdano: (2013)

Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice.
od: Walmsley, SR, et al.
Izdano: (2011)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
od: Lippl, K
Izdano: (2018)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
od: Lippl, K, et al.
Izdano: (2015)

Oxygen sensing by HIF hydroxylases.
od: Schofield, C, et al.
Izdano: (2004)

Signalling hypoxia by HIF hydroxylases.
od: Schofield, C, et al.
Izdano: (2005)

Hyperplasia of pulmonary neuroepithelial bodies (NEB) in lungs of prolyl hydroxylase -1(PHD-1) deficient mice
od: Pan, J, et al.
Izdano: (2012)

Hyperplasia of pulmonary neuroepithelial bodies (NEB) in lungs of prolyl hydroxylase -1(PHD-1) deficient mice.
od: Pan, J, et al.
Izdano: (2012)

Hyperplasia of Pulmonary Neuroepithelial Bodies (NEB) in Lungs of Prolyl Hydroxylase-1(PHD-1) Deficient Mice
od: Pan, J, et al.
Izdano: (2012)

Prolyl hydroxylases and therapeutics.
od: Smith, T, et al.
Izdano: (2010)

The HIF hydroxylase pathway and the tumour microenvironment
od: Ratcliffe, P
Izdano: (2008)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
od: Chen, R, et al.
Izdano: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
od: Chen, R, et al.
Izdano: (2014)